---
title: "First Bellwether Trial Today Against Reckitt Benckiser’s Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296097863.md"
description: "In Pensacola, Florida, a Reckitt Benckiser company, Mead Johnson, is undergoing the initial bellwether trial in a multidistrict litigation (MDL) at the US District Court for the Northern District of Illinois. The case, Inman v. Mead Johnson & Company, LLC, et al., involves their infant formula Enfamil allegedly associated with necrotizing enterocolitis (NEC) in a premature baby. This is the first lawsuit against Mead Johnson in the MDL to advance to trial. NEC is a serious intestinal condition that may …"
datetime: "2026-08-17T11:06:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296097863.md)
  - [en](https://longbridge.com/en/news/296097863.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296097863.md)
generator: "portal-rs"
---

# First Bellwether Trial Today Against Reckitt Benckiser’s Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio

In Pensacola, Florida, a Reckitt Benckiser company, Mead Johnson, is undergoing the initial bellwether trial in a multidistrict litigation (MDL) at the US District Court for the Northern District of Illinois. The case, Inman v. Mead Johnson & Company, LLC, et al., involves their infant formula Enfamil allegedly associated with necrotizing enterocolitis (NEC) in a premature baby. This is the first lawsuit against Mead Johnson in the MDL to advance to trial. NEC is a serious intestinal condition that may …

### Related Stocks

- [RKT.UK](https://longbridge.com/en/quote/RKT.UK.md)
- [RBGLY.US](https://longbridge.com/en/quote/RBGLY.US.md)
- [RBGLD.US](https://longbridge.com/en/quote/RBGLD.US.md)

## Related News & Research

- [Reckitt posts transcript from Barclays conference fireside chat in Boston](https://longbridge.com/en/news/298481963.md)
- [Reckitt shares rise after US jury backs unit Mead Johnson in baby formula case](https://longbridge.com/en/news/297621527.md)
- [04:17 ETEpicyt Pharma reports positive results in first-in-human study of BAFA in patients following gastric bypass surgery](https://longbridge.com/en/news/298283709.md)
- [BUB: Permanent FDA authorisation enables expansion in the US infant formula market and contract manufacturing](https://longbridge.com/en/news/298516212.md)
- [Frontieras North America Signs LOI With Cora Terminal for Multi-Phase FASForm(TM) Deployment in Illinois](https://longbridge.com/en/news/298480137.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**